MORN— AI Stock Forecast & Price Targets
Published 7/17/2026 · A free sample of K3vl4r’s AI-powered analysis.
Kronos price forecasts, scored fundamentals & technicals, and a multi-horizon plan.
View the live MORN price forecast →
Morningstar is a high-quality data/analytics franchise (30.7% ROE, 62% GM, ~$453M TTM FCF) trading at 12.9x forward EPS and 0.74 PEG after a -40% drawdown from 52W highs. The July 29 earnings print (~12 days away) is a binary catalyst dominating near-term risk/reward — confirmation of Q1'26's 24.2% operating margin trajectory and clarity on the $865M debt build determines whether the stock re-rates toward the $188-$200 zone or retests the $141 floor. Recent 5% weekly bounce and reclaim of the $173 pivot suggests positioning is neutralizing into the print, but I would not add aggressively into a binary event.
1-4 week view: HOLD current positions into the July 29 print; do NOT add size into a binary. The stock has already rallied ~5% off the July 10 low to reclaim $173, so risk/reward for a fresh long is asymmetrically worse than a week ago. If long, my stop is a decisive close below $164 (recent higher low + Kronos low band). A pre-earnings tactical add is only justified on a pullback to $167-$170 with tight risk to $161. Earnings stance: explicitly flat-to-modestly-long into the print — the Q1 24.2% op margin durability is the swing factor, and I will not underwrite gap-down risk with fresh capital. IV crush post-print means options are the wrong instrument here; stick to equity.
1-6 month view: Base case is a re-rating toward $188-$195 if Q2 confirms operating margin ≥ 23% and provides explicit CRSP integration/debt deployment color. Bull case ($210-$215) requires margin surprise above 25% plus a buyback authorization or accelerated CRSP revenue contribution. Bear case ($141-$150) triggers on margin miss below 22% or opaque debt disclosure. Expected return range from $176.29: -20% to +22%, skewed positive at 12.9x forward P/E and 0.74 PEG. What would change my mind: a Q2 operating margin below 22%, a further Sales Y/Y deceleration below 8%, or evidence CRSP integration is dilutive to margins.
1-3 year view: Morningstar retains a durable moat via PitchBook (private markets data monopoly-adjacent), DBRS (credible S&P/Moody's challenger), and the CRSP acquisition scaling index licensing across Vanguard's ETF/mutual fund ecosystem. Terminal thesis: a mid-teens FCF/share compounder with recurring revenue, indexed to global AUM growth and private market expansion. Structural bull driver: index/data becomes the toll road for the ETF industrialization thesis. Biggest structural risk: AI disintermediation of core research/ratings — LLM-native competitors could commoditize the fund-analytics tier, forcing pricing pressure by 2028-2029. Secondary risk: debt-financed M&A that fails to earn its cost of capital.
Revenue trajectory is accelerating — Q1'26 revenue of $644.8M represents +6.6% sequential growth vs. Q4'25's $641.1M and +10.8% Y/Y vs. Q1'25 comparable ($605.1M in Q2'25 base). Operating margin expanded sharply from 20.7% in Q3'25 to 21.4% in Q4'25 to 24.2% in Q1'26, a genuine inflection that is the crux of the thesis. Gross margin remains structurally elevated at 61-63%. Net income scaled from $89M (Q2'25) to $107.1M (Q1'26), a 20% lift. ROE of 30.7% and ROIC of 14.1% speak to franchise quality. However, the balance sheet has degraded materially: total debt jumped from $1.03B (Q2'25) to $1.91B (Q1'26) — an $874M build — while stockholders' equity contracted from $1.61B to $1.02B, pushing D/E to 1.87. This coincides with the CRSP acquisition, but explicit deployment disclosure is still pending. FCF quality remains solid at $453M TTM with 15.1x P/FCF, and the 21% payout ratio leaves ample capital allocation optionality. The Q1 FCF conversion dip to $53.6M is seasonal, not structural.
The 1h chart shows a strong rally from the July 10 low near $164 to a July 17 spike above $180, closing at $176.29 — a clean reclaim of the $173 pivot from the dossier's technical range. Kronos short-term forecasts a pullback to $163.73, but 1d directional accuracy (76%) is below the 86% naive baseline, so I discount this signal. The 4h chart shows a wide oscillation between $142 and $195 over six months, with price now near the middle. The 1d forecast projects $202 by early August with wide bands ($185-$215), aligning with the base case gate. Weekly chart shows price recovering from a January capitulation ($141.49 52W low) but still 40.6% below the $292.75 52W high — the drawdown magnitude leaves ample re-rating room if fundamentals confirm. Momentum: RSI 56 is neutral-bullish, +7.4% above SMA20, +1.7% above SMA50, but -9.2% below SMA200 — the longer-term downtrend has not been broken. Perf Week +5.0% shows positioning cover into earnings. Key levels: support $164 (recent higher low) then $155/$141 (structural floor); resistance $180 (recent high) then $185/$195 (Kronos band). Short float 8.6% with 3.3-day cover ratio adds squeeze fuel on a beat.
The signal-rich items are the CME Group multi-year derivatives licensing agreement (June 10), the Treasury Link launch (June 30), the CLO Daily Valued Index Suite launch with Houlihan Lokey (July 8), and the PitchBook 'Time to Exit' ML feature — collectively these expand the recurring/licensing revenue base and monetize proprietary data, directly supporting the operating leverage thesis. The June 25 8-K (Reg FD) and June 18 (Item 8.01) are worth watching but not called out as guidance-changing. The Simply Wall St piece flagging MORN as 26% above its fair value estimate is the notable bearish tell, and the June 20 analyst downgrade (rating 1.00 → 1.67) is a real, graded L2 bearish signal. Broader Morningstar research commentary (small-cap valuation, retirement sequence risk) is background noise for the ticker but reinforces the AUM-linked revenue story. Retail sentiment is nominally 100% bullish but volume is spam-heavy (identical WhatsApp promotion messages) — effectively no crowd signal.
- CRSP index licensing scaling across Vanguard's ETF/mutual fund ecosystem — direct AUM-linked revenue leverage
- CME Group multi-year derivatives licensing agreement (June 10) on Morningstar equity indexes creating new recurring revenue stream
- PitchBook 'Time to Exit' ML feature (July 11) monetizing proprietary private-market data with new premium tier potential
- CLO Daily Valued Index Suite launched with Houlihan Lokey (July 8) — enters structured credit indexing whitespace
- Treasury Link service (June 30) expands institutional trading product suite
- Morningstar DBRS/Credit segment continuing to gain share as a credible ratings challenger
- Operating margin inflection from 20.7% (Q3'25) → 24.2% (Q1'26) driving EPS operating leverage if durable
- Binary July 29 earnings event — op margin miss below 22% or weak guidance could gap the stock toward $150-$155
- Debt build from $1.03B (Q2'25) to $1.91B (Q1'26) with D/E now 1.87; requires clear ROIC disclosure on CRSP deployment
- Simply Wall St flags stock as 26% above fair value estimate; June 20 analyst downgrade (1.00 → 1.67) is a real bearish shift
- Stock -40.6% below 52W high and -20% YTD; downtrend not broken (price still -9.2% below SMA200)
- AI disintermediation of core research/ratings over 3-5 years — LLM-native competitors could commoditize fund analytics
- Short float 8.6% is elevated for a large-cap financial data name — signals active bearish positioning
- Insider transactions -1.07% and institutional transactions -3.16% show mild distribution
- Kronos short-term forecast (-7% to $163.73) diverges from mid-term forecast (+15% to $202) — signal inconsistency
Get AI analysis on any stock
This is one of hundreds of Kronos AI reports — scored fundamentals & technicals, bull/base/bear price targets, a multi-horizon plan, and continuously-updated forecasts across the market. Create a free account to explore them all.
Create your free account →Already a member? Sign in · Join our Discord